Evidence map›Paper›PMID 32643031›Full record

GuidelineWorld journal of urology2021

Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts.

Hesham Elghazaly, Nicolas Mottet, Jorge Garcia, Stephane Oudard, Mack Roach, Claude Abbou, Axel Merseburger, Amr Emara, Samir Shehata, Hesham Tawfik and 12 more

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 6 countries.

Hesham ElghazalyClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. heshamelghazaly@hotmail.com.
Nicolas MottetDepartment of Urology, University Hospital Nord St. Etienne, St. Etienne, France.
Jorge GarciaDepartment of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Stephane OudardDepartment of Medical Oncology, Georges Pompidou European Hospital, Paris, France.
Mack RoachDepartment of Radiation Oncology, University of California, San Francisco, CA, USA.
Claude AbbouDepartment of Urology, Hôpital Henri Mondor, Creteil, France.
Axel MerseburgerDepartment of Urology and Urologic Oncology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.
Amr EmaraDepartment of Urology, Hampshire Hospitals, NHS Foundation Trust, Basingstoke, UK.
Samir ShehataClinical Oncology Department, Assiut University Cancer Centre, Assiut, Egypt.
Hesham TawfikClinical Oncology Department, Tanta University, Tanta, Egypt.
Ola KhorshidMedical Oncology Department National Cancer Institute, Cairo University, Cairo, Egypt.
Ahmed SelimClinical Oncology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Akram AssemUrology Department, Alexandria University, Alexandria, Egypt.
Khalid AbdelkarimClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Lobna Ezz El-ArabClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Shouki BazarbashiMedical Oncology Department, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Abbass OmarDepartment of Clinical Oncology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Hesham ElwakilClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mohamed ElashryDepartment of Clinical Oncology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Mohamed Abou ElFotouhDepartment of Clinical Oncology, Faculty of Medicine, Menoufia University, Al Minufya, Egypt.
Tarek OsmanDepartment of Urology, Ain Shams University, Cairo, Egypt.
Mai Ezz El DinClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ain Shams University · EGAlexandria University · EGCairo University · EGAssiut University · EGCentre Hospitalier Universitaire de Saint-Étienne · FRCleveland Clinic · USHampshire Hospitals NHS Foundation Trust · GBHôpital Européen Georges-Pompidou · FRKing Faisal Specialist Hospital & Research Centre · SAMansoura University · EGMenoufia University · EGTanta University · EGUniversity Hospital Schleswig-Holstein · DEUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdvancements in the diagnosis and treatment of prostate cancer (PC) have rapidly progressed through the past years. Various factors should be taken into account while treating individual patients to ensure optimal and careful decision making. The purpose of this consensus review is to summarize the current practice patterns when managing patients with advanced prostate cancer (APC) as there is still a lack of or very limited evidence on its clinical management in some areas.

methodsPre-defined questions were shared with experts prior to the consensus session that took place in Cairo, Egypt in April 2019 during the 8th International gastrointestinal, liver and uro-oncology conference (IGILUC). Voting was based mainly on the expert opinions of the panel after a thorough discussion and review of available evidence from guidelines or best evidence available concerning the topic at hand.

resultsA strong consensus or unanimity was reached on 47% of the proposed questions. Notably, the panelists reached consensus on several topics based on high-level expert opinion. These findings contribute in several ways to our understanding of the management of PC and provide a basis for future recommendations. There was also a lack of consensus on other several topics, which suggests the need for further supporting data addressing these knowledge gaps.

conclusionThis review offers a thorough understanding of APC practice and offers insight on the various opinions shared amongst experts in the field that can serve as guidance regionally and deepens our understanding of disease management globally.

Indexed as

HumansMaleProstatic NeoplasmsAdvanced prostate cancerConsensusMetastatic prostate cancerProstate cancer

Identifiers

PMID32643031
OpenAlexW3041831761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.